{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:14:52Z","timestamp":1761851692928,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing Clinics of North America"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.cnur.2015.10.004","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T05:05:06Z","timestamp":1452661506000},"page":"29-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Platelet Inhibitors"],"prefix":"10.1016","volume":"51","author":[{"given":"Megan M.","family":"Shifrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Brian","family":"Widmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cnur.2015.10.004_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cnur.2015.10.004_bib2","first-page":"e29","article-title":"Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cnur.2015.10.004_bib3","first-page":"197","article-title":"Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor","volume":"1","author":"Birkeland","year":"2010","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.cnur.2015.10.004_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419","article-title":"Thrombopoetin: the primary regulator of platelet production","volume":"85","author":"Kaushansky","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cnur.2015.10.004_bib5","first-page":"349","article-title":"The bone marrow vascular niche: home of HSC differentiation and mobilization","volume":"20","author":"Kopp","year":"2005","journal-title":"Physiology (Bethesda)"},{"issue":"6","key":"10.1016\/j.cnur.2015.10.004_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.201304054","article-title":"The incredible journey: From megakaryocyte development to platelet formation","volume":"201","author":"Machlus","year":"2013","journal-title":"J\u00a0Cell Biol"},{"issue":"1","key":"10.1016\/j.cnur.2015.10.004_bib7","first-page":"3","article-title":"Localization of megakaryocytes in the bone marrow","volume":"15","author":"Tavassoli","year":"1989","journal-title":"Blood Cells"},{"issue":"4","key":"10.1016\/j.cnur.2015.10.004_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0049-3848(82)90163-3","article-title":"Evidence for a theory of physical fragmentation of megakaryocytes, implying that all platelets are produced in the pulmonary circulation","volume":"28","author":"Trowbridge","year":"1982","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.cnur.2015.10.004_bib9","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V95.8.2514","article-title":"Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers","volume":"95","author":"Harker","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cnur.2015.10.004_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.cnur.2015.10.004_bib11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.cnur.2015.10.004_bib12","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.cnur.2015.10.004_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/09537100050129305","article-title":"ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation","volume":"11","author":"Wilde","year":"2000","journal-title":"Platelets"},{"issue":"Suppl K","key":"10.1016\/j.cnur.2015.10.004_bib14","first-page":"88","article-title":"Cellular activation by thromboxane A2 and other eicosanoids","volume":"14","author":"Reilly","year":"1993","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.cnur.2015.10.004_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1538-7836.2011.04576.x","article-title":"Novel roles of cAMP\/cGMP-dependent signaling in platelets","volume":"10","author":"Smolenski","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cnur.2015.10.004_bib16","unstructured":"Use of aspirin for primary prevention of heart attack and stroke. Available at: http:\/\/www.fda.gov\/Drugs\/ResourcesForYou\/Consumers\/ucm390574.htm. Accessed June 12, 2015."},{"key":"10.1016\/j.cnur.2015.10.004_bib17","unstructured":"Aspirin: Comprehensive prescribing information. Available at: http:\/\/www.fda.gov\/ohrms\/DOCKETS\/ac\/03\/briefing\/4012B1_03_Appd 1-Professional Labeling.pdf. Accessed June 14, 2015."},{"issue":"3","key":"10.1016\/j.cnur.2015.10.004_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/157489007782418991","article-title":"Cilostazol: a new drug in the treatment intermittent claudication","volume":"2","author":"Kumar","year":"2007","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"issue":"11 Suppl","key":"10.1016\/j.cnur.2015.10.004_bib19","first-page":"S612","article-title":"Disposition of 14 C-cilostazol after single dose administration to healthy human subjects","volume":"14","author":"Bramer","year":"1997","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cnur.2015.10.004_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-8722-4-44","article-title":"Novel agents for anti-platelet therapy","volume":"4","author":"Ji","year":"2011","journal-title":"J\u00a0Hematol Oncol"},{"issue":"4","key":"10.1016\/j.cnur.2015.10.004_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40265-015-0364-3","article-title":"Clinical efficacy and safety of cilostazol: a critical review of the literature","volume":"75","author":"Rogers","year":"2015","journal-title":"Drugs"},{"issue":"21","key":"10.1016\/j.cnur.2015.10.004_bib22","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cnur.2015.10.004_bib23","article-title":"Antiplatelet and anticoagulation for patients with prosthetic heart valves","author":"Massel","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cnur.2015.10.004_bib24","unstructured":"Russell S, Slaughter M, Pagani F, et\u00a0al. HMII LVAS guidelines. Available at: http:\/\/www.fda.gov\/ohrms\/DOCKETS\/ac\/07\/briefing\/2007-4333b2-20-9_4 HM II Patient Management Guidelines.pdf. Accessed June 11, 2015."},{"key":"10.1016\/j.cnur.2015.10.004_bib25","unstructured":"Aggrenox prescribing information. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020884s030lbl.pdf. Accessed June 15, 2015."},{"key":"10.1016\/j.cnur.2015.10.004_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(83)90026-2","article-title":"Dipyridamole inhibition of adenosine metabolism in human blood","volume":"93","author":"Klabunde","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cnur.2015.10.004_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0049-3848(83)90356-0","article-title":"Mechanism of action of dipyridamole","volume":"4","author":"Harker","year":"1983","journal-title":"Thromb Res Suppl"},{"key":"10.1016\/j.cnur.2015.10.004_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.me.43.020192.001251","article-title":"The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis","volume":"43","author":"Parthasarathy","year":"1992","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.cnur.2015.10.004_bib29","series-title":"Drugs for the heart","first-page":"293","article-title":"Antithrombotic agents: platelet inhibitors, anticoagulants, and fibrinolytics","author":"Fox","year":"2009"},{"volume":"vol. 2","year":"2014","author":"Jacobson","key":"10.1016\/j.cnur.2015.10.004_bib30"},{"issue":"5","key":"10.1016\/j.cnur.2015.10.004_bib31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1185\/03007995.2014.880050","article-title":"Cangrelor: an emerging therapeutic option for patients with coronary artery disease","volume":"30","author":"Kubica","year":"2014","journal-title":"Curr Med Res Opin"}],"container-title":["Nursing Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0029646515001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0029646515001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:26:11Z","timestamp":1758446771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0029646515001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0029646515001127"],"URL":"https:\/\/doi.org\/10.1016\/j.cnur.2015.10.004","relation":{},"ISSN":["0029-6465"],"issn-type":[{"type":"print","value":"0029-6465"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Nursing Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cnur.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}